laudanosine은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

laudanosine은 임신 중 안전한가요?

No reproductive or teratogenic classification or safety assessment documents (no harmonised CLP reproductive hazard found on ECHA; no CIR or SCCS safety assessment located). Human/animal literature for laudanosine reports primarily CNS effects at high systemic concentrations after IV administration (metabolite of atracurium), not reproductive effects. Sources: ECHA substance page and clinical/pharmacology reviews. (ECHA substance information; PubMed/StatPearls reviews).

laudanosine은 모유 수유 중 안전한가요?

No data indicating reproductive or lactation-specific toxicity for topical exposure. Clinical literature describes laudanosine as a metabolite of atracurium with CNS stimulant effects at high systemic exposure, but no evidence of lactation-specific hazard from available literature and no regulatory reproductive classification found. (PubMed, StatPearls, ECHA).

laudanosine은 아기 피부에 안전한가요?

No infant-specific hazards identified in the literature. Exposure score increased by +1 for baby skin because topical absorption cannot be assumed zero and infant skin has higher absorption per the requested scoring rules; however there are no studies showing infant-specific toxicity or dermal absorption for cosmetic use. Clinical literature concerns are about systemic (IV) exposure, not topical. (StatPearls; PubMed reviews; ECHA substance page).

VeriMom은 laudanosine을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 laudanosine을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 laudanosine 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.